Telerehabilitation for Multiple Sclerosis

N/A
Waitlist Available
Led By Deborah Backus, PT, PhD
Research Sponsored by Shepherd Center, Atlanta GA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mild to moderate MS
Has limitations in walking but can walk 25 feet
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upchange from baseline at 8 weeks, at 16 weeks, at 6 months post intervention, and at 12 months post intervention
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will compare the effects of an exercise program done in a traditional gym setting versus at home using telerehabilitation.

Eligible Conditions
  • Multiple Sclerosis

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You have mild to moderate multiple sclerosis (MS).
Select...
You have difficulty walking but can walk a distance of 25 feet.
Select...
You are not currently involved in a strenuous exercise routine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 8 weeks, at 16 weeks, at 6 months post intervention, and at 12 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 8 weeks, at 16 weeks, at 6 months post intervention, and at 12 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Timed 25 Foot Walk Test (T25FWT)
Secondary outcome measures
Expanded Disability Status Scale
Godin Leisure-Time questionnaire
Modified Fatigue Impact Scale
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: TelerehabilitationActive Control1 Intervention
Participants will conduct the exercise program for people with MS at home and receive coaching via phone or Skype sessions.
Group II: Facility-based rehabilitationActive Control1 Intervention
Participants will conduct the exercise program for people with MS in a facility, for example a gym, or rehabilitation center. They will receive coaching on site at the facility.

Find a site

Who is running the clinical trial?

The Cleveland ClinicOTHER
993 Previous Clinical Trials
1,370,345 Total Patients Enrolled
19 Trials studying Multiple Sclerosis
3,749 Patients Enrolled for Multiple Sclerosis
Shepherd Center, Atlanta GALead Sponsor
26 Previous Clinical Trials
3,094 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
247 Patients Enrolled for Multiple Sclerosis
University of Alabama at BirminghamOTHER
1,509 Previous Clinical Trials
2,256,571 Total Patients Enrolled
36 Trials studying Multiple Sclerosis
4,904 Patients Enrolled for Multiple Sclerosis
University of North Carolina, Chapel HillOTHER
1,438 Previous Clinical Trials
4,069,763 Total Patients Enrolled
3 Trials studying Multiple Sclerosis
112 Patients Enrolled for Multiple Sclerosis
University of GeorgiaOTHER
92 Previous Clinical Trials
32,824 Total Patients Enrolled
University of Colorado, DenverOTHER
1,673 Previous Clinical Trials
1,661,871 Total Patients Enrolled
20 Trials studying Multiple Sclerosis
2,388 Patients Enrolled for Multiple Sclerosis
Marquette UniversityOTHER
60 Previous Clinical Trials
199,299 Total Patients Enrolled
3 Trials studying Multiple Sclerosis
191 Patients Enrolled for Multiple Sclerosis
Patient-Centered Outcomes Research InstituteOTHER
526 Previous Clinical Trials
29,948,035 Total Patients Enrolled
10 Trials studying Multiple Sclerosis
26,913 Patients Enrolled for Multiple Sclerosis
Tanner Foundation for Multiple SclerosisOTHER
2 Previous Clinical Trials
564 Total Patients Enrolled
1 Trials studying Multiple Sclerosis
20 Patients Enrolled for Multiple Sclerosis
Accelerated Cure Project for Multiple SclerosisOTHER
3 Previous Clinical Trials
27,638 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
23,226 Patients Enrolled for Multiple Sclerosis
Massachusetts General HospitalOTHER
2,833 Previous Clinical Trials
13,566,931 Total Patients Enrolled
9 Trials studying Multiple Sclerosis
1,590 Patients Enrolled for Multiple Sclerosis
Deborah Backus, PT, PhDPrincipal Investigator - Shepherd Center, Atlanta GA
Shepherd Center
1 Previous Clinical Trials
2 Total Patients Enrolled
Deborah Backus, PhDPrincipal Investigator - Shepherd Center, Atlanta GA
Shepherd Center

Media Library

Exercise program for people with MS Clinical Trial Eligibility Overview. Trial Name: NCT03468868 — N/A
Multiple Sclerosis Research Study Groups: Telerehabilitation, Facility-based rehabilitation
Multiple Sclerosis Clinical Trial 2023: Exercise program for people with MS Highlights & Side Effects. Trial Name: NCT03468868 — N/A
Exercise program for people with MS 2023 Treatment Timeline for Medical Study. Trial Name: NCT03468868 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In what locations can participants access this research experiment?

"In addition to the University of Colorado in Denver, University of Georgia in Athens, and Massachusetts General Hospital in Boston, there are 6 other potential sites for this clinical trial."

Answered by AI

Is this experiment currently accepting new participants?

"Clinicaltrials.gov states that the study, which was initially listed in July 2018 and last edited on October 2022, is no longer recruiting participants. Fortunately, there are currently 553 other clinical trails seeking volunteers for their research programs."

Answered by AI

Is the research team seeking elderly participants for this investigation?

"This medical study is inviting participants who are of legal age and below the senior citizen threshold."

Answered by AI

Is it possible to join this research study?

"The trial is seeking 400 patients who have been diagnosed with Multiple Sclerosis, aged between 18 and 65. To be accepted into the clinical trial, applicants must demonstrate limited walking ability of 25 feet or less, display mild to moderate MS symptoms, not engage in strenuous exercise activities regularly, and feasibly travel for assessments and training sessions at the appropriate medical centre."

Answered by AI
~12 spots leftby Dec 2023